SECTOR ANALYSIS

Endocrinology Oncology Biotech Companies

Grades, scores, and FDA catalyst signals for Endocrinology Oncology stocks tracked by BiotechSigns

← Full ScreenerFDA CalendarAll Sectors
Companies
22
Avg Score
60
Top Grade
A
Grade A
1
Endocrinology Oncology Companies22 tracked
TickerCompanyScoreGradeSectorSignals
ANTEAntriaBio92AEndocrinology
BOLTBolt Biotherapeutics79BOncology
NUVBNuvation Bio70BOncology
CRNXCrinetics Pharmaceuticals69BEndocrinology
HOOKHOOKIPA Pharma67BOncology
LBPHLongboard Pharmaceuticals66BOncology
HCMHUTCHMED China65BOncology
DCPHDeciphera Pharmaceuticals64COncology
KPTIKaryopharm Therapeutics64COncology
KURAKura Oncology, Inc.63COncology
CELCCelcuity Inc59COncology
TOIThe Oncology Institute, Inc.59COncology
INCYIncyte Corporation56COncology
CORTCorcept Therapeutics54CEndocrinology
KRONKronos Bio53COncology
CRVSCorvus Pharmaceuticals53COncology
BMYBristol-Myers Squibb52COncology
ALXOALX Oncology51COncology
SNDXSyndax Pharmaceuticals49DOncology
TGTXTG Therapeutics48DOncology
BCABBioAtla Inc47DOncology
BGNEBeiGene Ltd44DOncology
Not financial advice. All data and analysis provided by Guerilla Finance Inc. BiotechSigns grades and scores are algorithmic signals only and do not constitute investment recommendations. Biotech investing involves significant risk, including the potential for complete loss of capital on binary FDA events. Always conduct your own due diligence before making investment decisions.